UTHR

United Therapeutics Corporation

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$564.81

Market Cap

$24.75B

Beta

0.75

P/E

20.9

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+10.61%

EPS Growth (YoY)+13.25%

Revenue CAGR 3Y+18.02%

P/E Ratio20.9

PEG Ratio1.53

FCF Yield+4.20%

Debt / Equity0.00

Interest Coverage76.5x

No credit card required

Already have an account? Sign in to view the full analysis for UTHR.